临床病理特征 | β | SE | χ2 | HR | 95.0%CI | p值 | |
分子亚型 |
|
|
|
|
|
|
|
三阴性 |
|
| 2.322 | 1 |
|
| 0.313 |
HER-2阳性 | −1.001 | 1.092 | 0.841 | 0.368 | 0.043~3.122 | 0.359 | |
Luminal | 0.598 | 0.789 | 0.576 | 1.819 | 0.388~8.533 | 0.448 | |
治疗线数 | 0.343 | 0.957 | 0.128 | 1.409 | 0.216~9.199 | 0.343 | |
年龄 | 0.028 | 0.749 | 0.001 | 1.028 | 0.237~4.463 | 0.970 | |
疗效评价 |
|
|
|
|
|
|
|
PD |
|
| 8.015 | 1 |
|
| 0.018 |
PR | −2.980 | 1.266 | 5.541 | 0.051 | 0.004~0.607 | 0.019 | |
SD | −2.242 | 0.885 | 6.423 | 0.106 | 0.019~0.602 | 0.011 |